HAMED KAMAL
Known title: Chief Medical OfficerCIK: 0001946366
Associated companies
Transaction History
| SPRO | ▼ Sell | Open Market | 28,075 | $38K | 2/2/2024 | View on chart |
| SPRO | ▲ Buy | Grant | 239,731 | $0 | 2/1/2024 | View on chart |
| SPRO | ▼ Sell | Open Market | 39,496 | $50K | 9/13/2023 | View on chart |
| SPRO | ▲ Buy | Grant | 140,000 | $0 | 6/12/2023 | View on chart |
| SPRO | ▲ Buy | Grant | 265,957 | $0 | 2/1/2023 | View on chart |
| SPRO | ▲ Buy | Grant | 210,000 | $0 | 9/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
SPRO among stocks that gapped in Tuesday's session
Spero Therapeutics was listed as a gapping stock on Tuesday, meaning its price opened significantly different from the previous close. Such gaps often reflect a quick shift in market sentiment. The move occurs while the stock is near its $1.19 support level and has a neutral RSI around 49.
SPRO among stocks that gapped in Tuesday's session. Spero Therapeutics was listed as a gapping stock on Tuesday, meaning its price opened significantly different from the previous close. Such gaps often reflect a quick shift in market sentiment. The move occurs while the stock is near its $1.19 support level and has a neutral RSI around 49.